Press release
Dry Age Macular Degeneration Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Astellas Pharma, Iveric Bio, Apellis Pharma, Novartis, Alkeus Pharma, Belite Bio
"Dry Age Macular Degeneration Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Dry Age Macular Degeneration Market.
The Dry Age Macular Degeneration Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Dry Age Macular Degeneration Pipeline Report:
*
Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies with a considerable amount of success over the years.
*
Dry Age Macular Degeneration companies working in the treatment market are Astellas Pharma/Iveric Bio, Apellis Pharmaceuticals, Novartis, Alkeus Pharmaceuticals, Belite Bio, Inflammx Therapeutics, Ocugen, OliX Pharmaceuticals, Gensight Biologics, and others, are developing therapies for the Dry Age Macular Degeneration treatment
*
Emerging Dry Age Macular Degeneration therapies in the different phases of clinical trials are- IZERVAY (avacincaptad pegol), SYFOVRE (pegcetacoplan), Iptacopan (LNP023), ALK-001, Tinlarebant (LBS-008), XIFLAM, OCU410, OLX301A, GS030, and others are expected to have a significant impact on the Dry Age Macular Degeneration market in the coming years.
*
Potential therapies expected to drive notable changes during the upcoming forecast period include AVD-104, Tinlarebant (LBS-008), Gildeuretinol (ALK-001), Elamipretide, ANX007, Danicopan (ALXN2040), IONIS-FB-LRx (RG6299), JNJ-1887, CPCB-RPE1, OpRegen, and others.
*
In February 2025, Luxa Biotechnology announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its RPESC-RPE-4W transplantation for the treatment of dry age-related macular degeneration (dry AMD). The company is developing this innovative adult retinal pigment epithelial stem cell therapy for patients with dry AMD.
*
In November 2024, The U.S. FDA approved LumiThera's Valeda Light Delivery System for marketing as a treatment for dry age-related macular degeneration (AMD).
Dry Age Macular Degeneration Overview
Dry age-related macular degeneration (AMD) involves a gradual breakdown of macular cells over an extended period. This occurs as retinal cells decline without renewal. It's important to note that the term 'dry' doesn't imply dry eyes but rather distinguishes it from wet AMD.
Get a Free Sample PDF Report to know more about Dry Age Macular Degeneration Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight [https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Dry Age Macular Degeneration Drugs Under Different Phases of Clinical Development Include:
*
IZERVAY (avacincaptad pegol): Astellas Pharma/Iveric Bio
*
SYFOVRE (pegcetacoplan): Apellis Pharmaceuticals
*
Iptacopan (LNP023): Novartis
*
ALK-001: Alkeus Pharmaceuticals
*
Tinlarebant (LBS-008): Belite Bio
*
XIFLAM: Inflammx Therapeutics
*
OCU410: Ocugen
*
OLX301A: OliX Pharmaceuticals
*
GS030: Gensight Biologics
Dry Age Macular Degeneration Route of Administration
Dry Age Macular Degeneration pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Intra-articular
*
Intraocular
*
Intrathecal
*
Intravenous
*
Ophthalmic
*
Oral
*
Parenteral
*
Subcutaneous
*
Topical
*
Transdermal
Dry Age Macular Degeneration Molecule Type
Dry Age Macular Degeneration Products have been categorized under various Molecule types, such as
*
Oligonucleotide
*
Peptide
*
Small molecule
Dry Age Macular Degeneration Pipeline Therapeutics Assessment
*
Dry Age Macular Degeneration Assessment by Product Type
*
Dry Age Macular Degeneration By Stage and Product Type
*
Dry Age Macular Degeneration Assessment by Route of Administration
*
Dry Age Macular Degeneration By Stage and Route of Administration
*
Dry Age Macular Degeneration Assessment by Molecule Type
*
Dry Age Macular Degeneration by Stage and Molecule Type
DelveInsight's Dry Age Macular Degeneration Report covers around 80+ products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further Dry Age Macular Degeneration product details are provided in the report. Download the Dry Age Macular Degeneration pipeline report to learn more about the emerging Dry Age Macular Degeneration therapies [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the Dry Age Macular Degeneration Therapeutics Market include:
Key companies developing therapies for Dry Age Macular Degeneration are - Janssen Research & Development, Belite Bio, Katairo, Cognition Therapeutics, Eye Co Pty Ltd, Applied Genetic Technologies Corporation (AGTC), Aviceda Therapeutics, Kodiak Sciences, Ascentage Pharma, OliX Pharmaceutical, Nanoscope Therapeutics, Inc., Biophytis, Eyestem, Eyevensys, SanBio, Beta Therapeutics, MacRegen, Amarna Therapeutics, MeiraGTx, Cognition Therapeutics, Ocugen, Catalyst Biosciences, Endogena Therapeutics, Oculogenex, Clover Therapeutics, and others.
Dry Age Macular Degeneration Pipeline Analysis:
The Dry Age Macular Degeneration pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of Dry Age Macular Degeneration with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Dry Age Macular Degeneration Treatment.
*
Dry Age Macular Degeneration key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
Dry Age Macular Degeneration Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Dry Age Macular Degeneration market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Dry Age Macular Degeneration drugs and therapies [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Dry Age Macular Degeneration Pipeline Market Drivers
*
Growing geriatric population and rising prevalence of AMD, robust pipeline for dry AMD treatment are some of the important factors that are fueling the Dry Age Macular Degeneration Market.
Dry Age Macular Degeneration Pipeline Market Barriers
*
However, lack of awareness about dry AMD, lengthy and expensive clinical trials, lack of early detection and other factors are creating obstacles in the Dry Age Macular Degeneration Market growth.
Scope of Dry Age Macular Degeneration Pipeline Drug Insight
*
Coverage: Global
*
Key Dry Age Macular Degeneration Companies: Astellas Pharma/Iveric Bio, Apellis Pharmaceuticals, Novartis, Alkeus Pharmaceuticals, Belite Bio, Inflammx Therapeutics, Ocugen, OliX Pharmaceuticals, Gensight Biologics, and others
*
Key Dry Age Macular Degeneration Therapies: IZERVAY (avacincaptad pegol), SYFOVRE (pegcetacoplan), Iptacopan (LNP023), ALK-001, Tinlarebant (LBS-008), XIFLAM, OCU410, OLX301A, GS030, and others
*
Dry Age Macular Degeneration Therapeutic Assessment: Dry Age Macular Degeneration current marketed and Dry Age Macular Degeneration emerging therapies
*
Dry Age Macular Degeneration Market Dynamics: Dry Age Macular Degeneration market drivers and Dry Age Macular Degeneration market barriers
Request for Sample PDF Report for Dry Age Macular Degeneration Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Dry Age Macular Degeneration Report Introduction
2. Dry Age Macular Degeneration Executive Summary
3. Dry Age Macular Degeneration Overview
4. Dry Age Macular Degeneration- Analytical Perspective In-depth Commercial Assessment
5. Dry Age Macular Degeneration Pipeline Therapeutics
6. Dry Age Macular Degeneration Late Stage Products (Phase II/III)
7. Dry Age Macular Degeneration Mid Stage Products (Phase II)
8. Dry Age Macular Degeneration Early Stage Products (Phase I)
9. Dry Age Macular Degeneration Preclinical Stage Products
10. Dry Age Macular Degeneration Therapeutics Assessment
11. Dry Age Macular Degeneration Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Dry Age Macular Degeneration Key Companies
14. Dry Age Macular Degeneration Key Products
15. Dry Age Macular Degeneration Unmet Needs
16 . Dry Age Macular Degeneration Market Drivers and Barriers
17. Dry Age Macular Degeneration Future Perspectives and Conclusion
18. Dry Age Macular Degeneration Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dry-age-macular-degeneration-pipeline-2025-key-companies-moa-roa-and-clinical-trials-evaluation-by-delveinsight-astellas-pharma-iveric-bio-apellis-pharma-novartis-alkeus-pharma-belite-bio]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age Macular Degeneration Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Astellas Pharma, Iveric Bio, Apellis Pharma, Novartis, Alkeus Pharma, Belite Bio here
News-ID: 4351465 • Views: …
More Releases from ABNewswire
World-Renowned Comedy Sensation Tape Face to Perform Live Aboard Star Voyager fr …
StarCruises is delighted to announce that Star Voyager will bring laughter to the high seas as internationally acclaimed silent comedy star Tape Face takes the stage for a limited-time performance run from 9 January to 5 February 2026 sailings, during the ship's seasonal deployment from Singapore and Kuala Lumpur (via Port Klang).
14 January, 2026 - Singapore - StarCruises is delighted to announce that Star Voyager willbring laughter to the high…
Door Insulation Market 2026: Business Strategies for Excellent Growth, Highest R …
The Door Insulation Market is growing steadily, driven by rising demand for energy-efficient buildings, soundproofing, and thermal comfort in residential and commercial spaces. Key players such as Owens Corning, Saint-Gobain, BASF SE, Kingspan Group, and Knauf Insulation are focusing on advanced insulation materials and sustainable solutions to improve energy performance and meet stringent building regulations.
The door insulation market is projected to reach USD 1.7 billion by 2029, at a CAGR…
TexasWholeLifeInsurance.com Launches to Provide Lifetime Coverage and Cash Value …
TexasWholeLifeInsurance.com, a new website from Baxter Insurance Agency, Inc., is now live, offering a detailed guide to whole life insurance in Texas, including key benefits, rates, and options for securing lifetime coverage.
HOUSTON, TX - Jan 16, 2026 - Baxter Insurance Agency, Inc., a leading provider of insurance solutions in Texas for over 40 years, is excited to announce the launch of TexasWholeLifeInsurance.com. This new platform is dedicated to educating Texans…
Green Water Treatment Chemicals Market 2026-2029: Growth Overview, Facts & Figur …
The Green Water Treatment Chemicals Market is gaining traction due to rising environmental regulations, water scarcity concerns, and demand for sustainable treatment solutions. Key players such as BASF SE, Ecolab, Solenis, Kemira, and SUEZ are focusing on bio-based, low-toxicity chemicals to improve water quality while reducing environmental impact across municipal and industrial applications.
The Green water treatment chemicals market is projected to reach USD 2.25 billion by 2029 from USD 1.70…
More Releases for Dry
Rising Prevalence Of Dry Eye Conditions Boosts Growth In Dry Eye Products Market …
The Dry Eye Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dry Eye Products Market Size During the Forecast Period?
In recent years, there has been a significant expansion in the market size of dry eye products. The market is projected…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Dry Eye Market - Advancing Eye Wellness: Dry Eye Solutions Revolutionizing Relie …
Newark, New Castle, USA - new report, titled Dry Eye Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Dry Eye market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Dry Eye market. The report offers an overview of the market, which…
Dry Lubricants Market Size to Hit $ 813.78 Million by 2028 | Dry Lubricants Indu …
According to our experience research team, Dry Lubricants Market was valued at USD 755.42 Million in 2021, and the global Dry Lubricants industry is projected to reach a value of USD 813.78 Million by 2028, at a CAGR of 1.2% during the forecast period 2022-2028
The report is focused on gaining various Dry Lubricants market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Dry Ice Market In-Depth Analysis | Key Participants Dry Ice Corp., Dry Ice UK Lt …
Demand for dry ice is expected to magnify with the development of dry ice machines industry across the globe. Manufacturers in large multinational organizations and private firms have been contributing prominently in the revenue growth of dry ice market. Dry ice being a cost-effective product is expected to bolster its demand across various applications in the near future. Rising number of fire accidents leads to increasing demand for dry ice,…
Dry Screw Vacuum Pumps
Swam Dry vacuum pumps are the latest development in the vacuum pump industry. They offer a number of advantages over traditional vacuum pump designs. Best process gas blowers. There is “NO OIL / NO WATER” contact with the process vapours, which is why they are considered extremely environmentally friendly.
Visit us for more info - http://swamatics.com/ProductDetails.aspx?prod=Process%20Gas%20Blowers/Gas%20Boosters
The definition of a dry vacuum pump is a pump that does not use any…
